Keyphrases
Huntington's Disease
100%
PSP Scale
45%
Progressive Supranuclear Palsy
44%
Frontotemporal Dementia
44%
Phase II Study
29%
Placebo-controlled
25%
Randomized Double-blind
25%
Plasma Neurofilament Light Chain
25%
Rating Scales
25%
Volition
22%
Premanifest Huntington's Disease
22%
Gosuranemab
22%
Color Key
22%
Clinical Outcomes
22%
Functional Connectivity
22%
COVID-19
22%
Gene mutation
22%
Impulse Control Disorders
22%
Antibody Blockade
22%
Cerebral Oxygenation
22%
Fluid Biomarkers
22%
Striatum
22%
Disease Progression
22%
Dyskinesia
22%
Motor Circuit
22%
Phase II Trial
22%
Pediatric Onset
22%
Educational Attainment
22%
Phosphorylated tau181
22%
Neurofilament Light (NF-L)
22%
Pearl
22%
Fellowship Training
22%
Movement Disorders
22%
Angiographic Outcome
22%
Visual Stimulation
22%
Giant Intracranial Aneurysm
22%
Quality of Life Scale
22%
Aneurysm
22%
Epilepsy
22%
Parkinson's Disease
22%
Single-center Experience
22%
Dopamine Dysregulation Syndrome
22%
Semaphorin 4D
22%
Disease Course
22%
Progranulin mutation
22%
Tissue Biomarkers
22%
Spinocerebellar Ataxia Type 3 (SCA3)
22%
Bioresources
22%
Age of Onset
22%
Dementia with Lewy Bodies
22%
Medicine and Dentistry
Huntington's Disease
88%
Progressive Supranuclear Palsy
88%
Placebo
47%
Magnetic Resonance Imaging
46%
Stereotypic Movement Disorder
45%
Quality of Life
44%
Clinical Trial
42%
Rating Scale
42%
Shy-Drager Syndrome
29%
Cerebral Atrophy
27%
Gosuranemab
22%
Transmissible Spongiform Encephalopathy
22%
Semaphorin
22%
Parkinson's Disease
22%
Frontotemporal Lobar Degeneration
22%
Pediatrics
22%
Intracranial Aneurysm
22%
Light Chain
22%
Neurofilament
22%
Aneurysm
22%
Postsynaptic Potential
22%
Peripheral Neuropathy
22%
Medicine
22%
Lumbar Puncture
22%
COVID-19
22%
Diarrhea
22%
Laquinimod
22%
Epileptic Seizure
17%
Disease
17%
Cerebrospinal Fluid
16%
Biological Marker
14%
Prion
14%
Amyloidosis
14%
Midbrain
12%
Family History
11%
Symptom
11%
Adverse Event
9%
Clinical Global Impression
8%
Telemedicine
8%
Disease Course
8%
Volunteer
7%
DNA Template
7%
Diagnosis of Parkinson's Disease
7%
Autosomal Dominant Inheritance
7%
Onset Age
7%
Neurofibrillary Tangle
7%
Patient with Meningitis
7%
Neuropathy
7%
Epileptic Absence
7%
Health Care Cost
7%
Neuroscience
Huntington's Disease
88%
Progressive Supranuclear Palsy
71%
Postsynaptic Potential
52%
Parkinson's Disease
48%
Neurofilament Light Chain
44%
Frontotemporal Dementia
44%
Multiple System Atrophy
38%
CAG Repeat
30%
Striatum
27%
Atypical Parkinsonism
26%
Parkinsonism
23%
Dyskinesia
22%
Impulse Control Disorder
22%
Gene Mutation
22%
Spinocerebellar Ataxia
22%
Semaphorin
22%
Basal Ganglia
22%
Transmissible Spongiform Encephalopathy
22%
Functional Connectivity
22%
Ataxia
22%
Placebo
22%
Progranulin
22%
Metabolic Pathway
22%
Peripheral Neuropathy
22%
Prion
20%
Magnetic Resonance Imaging
17%
Stereotypic Movement Disorder
17%
Amyloidosis
14%
Huntingtin
13%
Putamen
11%
Globus pallidus
11%
Nucleus Accumbens
11%
Substantia nigra
11%
Magnetic Resonance Imaging
10%
Dementia with Lewy Bodies
8%
Dysautonomia
8%
Neurodegenerative Disorder
7%
Executive Functions
7%
Nonsense Mutation
7%
Functional Magnetic Resonance Imaging
7%
Diagnosis of Parkinson's Disease
7%
Epileptic Absence
7%
Peripheral Neuropathy
7%
DNA Template
7%
Treatment of Parkinson's Disease
7%
Alzheimer's Disease
5%
Polyglutamine
5%
Cytosine
5%
Adenine
5%
Guanine
5%